The most common cholesterol-lowering drugs may improve hospitalised Covid-19 patients’ chances of survival and reduce their risks of progressing to more severe disease, a new study suggests.
An analysis of more than 10,000 people admitted to more than 140 hospitals across the United States found that a class of medications called statins, together with blood pressure drugs, reduced in-hospital Covid-19 death by 40% among those who took them before being admitted.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
